Chemoinformaics analysis of 2,5-Dimethyl-3-pentylpyrazine
Molecular Weight | 178.279 | nRot | 4 |
Heavy Atom Molecular Weight | 160.135 | nRig | 12 |
Exact Molecular Weight | 178.147 | nRing | 1 |
Solubility: LogS | -2.201 | nHRing | 1 |
Solubility: LogP | 1.456 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 32.5723 |
nHD | 0 | BPOL | 20.3377 |
QED | 0.828 |
Synth | 2.179 |
Natural Product Likeliness | 0.193 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.007 |
Pgp-sub | 0.006 |
HIA | 0.006 |
CACO-2 | -4.683 |
MDCK | 0.0000327 |
BBB | 0.988 |
PPB | 0.602401 |
VDSS | 1.265 |
FU | 0.272441 |
CYP1A2-inh | 0.695 |
CYP1A2-sub | 0.979 |
CYP2c19-inh | 0.357 |
CYP2c19-sub | 0.906 |
CYP2c9-inh | 0.048 |
CYP2c9-sub | 0.844 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.857 |
CYP3a4-inh | 0.093 |
CYP3a4-sub | 0.599 |
CL | 6.178 |
T12 | 0.524 |
hERG | 0.039 |
Ames | 0.514 |
ROA | 0.744 |
SkinSen | 0.197 |
Carcinogencity | 0.125 |
EI | 0.268 |
Respiratory | 0.657 |
NR-Aromatase | 0.489 |
Antiviral | No |
Prediction | 0.707891 |